Trial intelligence / Profile preview

Effect of Itraconazole on Duavee PK in Non-Obese and Obese Women

NCT02100553Phase 1Completed

Sponsor
Pfizer
Start
Apr 2014
Primary completion
Jun 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label trial of bazedoxifene + conjugated estrogens in vasomotor symptoms and postmenopausal osteoporosis (2 arms), sponsored by Pfizer. Primary endpoints: Area Under the Curve From Time Zero to Extrapolated Infinite Time up to 96 hours and Maximum Observed Plasma Concentration up to 96 hours. Started Apr 2014; status: completed.

02

Drugs

bazedoxifene + conjugated estrogens
03

Conditions

vasomotor symptomspostmenopausal osteoporosis

Beyond the preview

Go deeper on NCT02100553.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02100553.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call